Heparin-induced thrombocytopenia differential diagnosis: Difference between revisions
Shyam Patel (talk | contribs) No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
(9 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Heparin-induced_thrombocytopenia]] | |||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com] | {{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com] {{shyam}} | ||
==Overview== | ==Overview== | ||
[[Heparin-induced thrombocytopenia]] is diagnosed when the [[platelet]] count falls by > 50% typically after 5-10 days of [[heparin]] therapy. It should be differentiated by other causes of thrombocytopenia like hemolytic uremic syndrome, Thrombotic thrombocytopenia and | [[Heparin-induced thrombocytopenia]] is diagnosed when the [[platelet]] count falls by > 50% typically after 5-10 days of [[heparin]] therapy. It should be differentiated by other causes of thrombocytopenia like [[Hemolytic-uremic syndrome|hemolytic uremic syndrome]], t[[Thrombotic thrombocytopenia|hrombotic thrombocytopenia]], [[disseminated intravascular coagulation]], [[post-transfusion purpura]], and [[systemic lupus erythematosis]]. | ||
==Differential diagnosis== | ==Differential diagnosis== | ||
HIT must be differentiated from other diseases that present with thrombocytopenia. Please scroll down to view the table. | |||
{| class="wikitable" | {| class="wikitable" | ||
! scope="col" | Characteristic/Parameter | ! scope="col" | Characteristic/Parameter | ||
! scope="col" | '''HIT''' | ! scope="col" | '''HIT''' | ||
! scope="col" | '''DIC''' | ! scope="col" | '''DIC''' | ||
! scope="col" | '''HUS''' | ! scope="col" | '''HUS'''<ref name="pmid28416508">{{cite journal| author=Jokiranta TS| title=HUS and atypical HUS. | journal=Blood | year= 2017 | volume= 129 | issue= 21 | pages= 2847-2856 | pmid=28416508 | doi=10.1182/blood-2016-11-709865 | pmc=5445567 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28416508 }} </ref> | ||
! scope="col" | '''Atypical HUS''' | |||
! scope="col" | '''ITP''' | ! scope="col" | '''ITP''' | ||
! scope="col" | '''PTP''' | ! scope="col" | '''PTP''' | ||
Line 28: | Line 20: | ||
|- | |- | ||
! scope="row" | Symptoms | ! scope="row" | Symptoms | ||
| Bleeding, thrombosis, skin necrosis | | [[Bleeding]], [[thrombosis]], [[Necrosis|skin necrosis]] | ||
| Bleeding, thrombosis, petechiae, sepsis | | [[Bleeding]], [[thrombosis]], [[petechiae]], [[sepsis]] | ||
| Renal failure, hematuria, bleeding | | [[Renal failure]], [[hematuria]], [[bleeding]], [[microangiopathic hemolytic anemia]] | ||
| Petechiae, bleeding, other autoimmune diseases | | [[Renal failure]], [[hematuria]], [[bleeding]], [[microangiopathic hemolytic anemia]] | ||
| | | [[Petechiae]], [[bleeding]], other [[autoimmune diseases]] | ||
| Bleeding, photosensitivity, arthritis, malar rash, discoid rash, renal failure, seizures, psychosis | | [[Petechia]]<nowiki/>e, [[purpura]], [[ecchymoses]] | ||
| [[Bleeding]], [[photosensitivity]], [[arthritis]], [[malar rash]], discoid rash, [[Renal insufficiency|renal failure]], [[seizures]], [[psychosis]] | |||
|- | |- | ||
! scope="row" | Platelet count | ! scope="row" | Platelet count | ||
| | | Low but usually more than 20000 per microliter | ||
| | | Low | ||
| Low | |||
| Low | |||
| Low; can be as low as 10000 per microliter | |||
| Low; can be less than 10000 per microliter; sudden onset after [[transfusion]] | |||
| Variable; usually low | |||
|- | |- | ||
! scope="row" | PT and PTT | ! scope="row" | PT and PTT | ||
| | | Normal | ||
| | | Elevated | ||
| Normal | |||
| Normal | |||
| Normal | |||
| Normal | |||
| Usually normal | |||
|- | |- | ||
! scope="row" | | ! scope="row" | Etiology | ||
| | | [[Heparin]] exposure | ||
| | | [[Sepsis]], delivery of fetus, [[acute promyelocytic leukemia]], other [[malignancy]] | ||
| [[Escherichia coli O157:H7|E.coli strain O157:H7]]; [[Shiga-like toxin]] | |||
| Dysregulation of [[Complement|complement activation]]; mutation in [[Factor H|complement factor H]] | |||
| Idiopathic; can be secondary to [[chronic lymphocytic leukemia]], [[Human Immunodeficiency Virus (HIV)|HIV]], [[Hepatitis|viral hepatitis]], [[H. pylori]] | |||
| Exposure to transfused products | |||
| Autoimmunity with development of [[antibodies]] to [[DNA]] | |||
|- | |- | ||
! scope="row" | Drug-related | ! scope="row" | Drug-related | ||
| | | Yes, always | ||
| | | Possible | ||
| No | |||
| No | |||
| Yes | |||
| No; transfusion-related | |||
| Possible; drug-induced lupus can be caused by medications like [[hydralazine]] or [[isoniazid]] | |||
|- | |- | ||
! scope="row" | Bleeding | ! scope="row" | Bleeding | ||
| | | Possible | ||
| | | Usually | ||
| Usually | |||
| Usually | |||
| Yes; spontaneous bleeding if [[platelet]] count < 10000 per microliter | |||
| Yes; spontaneous bleeding if platelet count < 10000 per microliter | |||
| Rare | |||
|} | |} | ||
Table legend: HIT, heparin-induced thrombocytopenia; DIC, disseminated intravascular coagulation; HUS, hemolytic-uremic syndrome; ITP, immune thrombocytopenia purpura; PTP, post-transfusion purpura; SLE, systemic lupus erythematosis | Table legend: '''HIT''', heparin-induced thrombocytopenia; '''DIC''', disseminated intravascular coagulation; '''HUS''', hemolytic-uremic syndrome; '''ITP''', immune thrombocytopenia purpura; '''PTP''', post-transfusion purpura; '''SLE''', systemic lupus erythematosis | ||
==Reference== | ==Reference== | ||
{{Reflist|2}} | {{Reflist|2}} |
Latest revision as of 21:08, 26 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2] Shyam Patel [3]
Overview
Heparin-induced thrombocytopenia is diagnosed when the platelet count falls by > 50% typically after 5-10 days of heparin therapy. It should be differentiated by other causes of thrombocytopenia like hemolytic uremic syndrome, thrombotic thrombocytopenia, disseminated intravascular coagulation, post-transfusion purpura, and systemic lupus erythematosis.
Differential diagnosis
HIT must be differentiated from other diseases that present with thrombocytopenia. Please scroll down to view the table.
Characteristic/Parameter | HIT | DIC | HUS[1] | Atypical HUS | ITP | PTP | SLE |
---|---|---|---|---|---|---|---|
Symptoms | Bleeding, thrombosis, skin necrosis | Bleeding, thrombosis, petechiae, sepsis | Renal failure, hematuria, bleeding, microangiopathic hemolytic anemia | Renal failure, hematuria, bleeding, microangiopathic hemolytic anemia | Petechiae, bleeding, other autoimmune diseases | Petechiae, purpura, ecchymoses | Bleeding, photosensitivity, arthritis, malar rash, discoid rash, renal failure, seizures, psychosis |
Platelet count | Low but usually more than 20000 per microliter | Low | Low | Low | Low; can be as low as 10000 per microliter | Low; can be less than 10000 per microliter; sudden onset after transfusion | Variable; usually low |
PT and PTT | Normal | Elevated | Normal | Normal | Normal | Normal | Usually normal |
Etiology | Heparin exposure | Sepsis, delivery of fetus, acute promyelocytic leukemia, other malignancy | E.coli strain O157:H7; Shiga-like toxin | Dysregulation of complement activation; mutation in complement factor H | Idiopathic; can be secondary to chronic lymphocytic leukemia, HIV, viral hepatitis, H. pylori | Exposure to transfused products | Autoimmunity with development of antibodies to DNA |
Drug-related | Yes, always | Possible | No | No | Yes | No; transfusion-related | Possible; drug-induced lupus can be caused by medications like hydralazine or isoniazid |
Bleeding | Possible | Usually | Usually | Usually | Yes; spontaneous bleeding if platelet count < 10000 per microliter | Yes; spontaneous bleeding if platelet count < 10000 per microliter | Rare |
Table legend: HIT, heparin-induced thrombocytopenia; DIC, disseminated intravascular coagulation; HUS, hemolytic-uremic syndrome; ITP, immune thrombocytopenia purpura; PTP, post-transfusion purpura; SLE, systemic lupus erythematosis
Reference
- ↑ Jokiranta TS (2017). "HUS and atypical HUS". Blood. 129 (21): 2847–2856. doi:10.1182/blood-2016-11-709865. PMC 5445567. PMID 28416508.